Lv6
1960 积分 2023-07-17 加入
HER3-addicted tumors: how biotechs are closing in
16天前
已完结
An Overview of CDK Enzyme Inhibitors in Cancer Therapy
5个月前
已完结
CDK inhibitors from past to present: A new wave of cancer therapy
5个月前
已完结
Small-molecule degraders of cyclin-dependent kinase protein: a review
5个月前
已完结
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
5个月前
已完结
Applications of Bioisosteres in the Design of Biologically Active Compounds
5个月前
已完结
From target discovery to clinical drug development with human genetics
7个月前
已完结
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin
8个月前
已完结
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
8个月前
已完结
Current strategies and progress for targeting the “undruggable” transcription factors
9个月前
已完结
皖公网安备34019202002308
